Truist Financial’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,650
Closed -$265K 2936
2026
Q1
$265K Sell
11,650
-15,115
-56% -$357K ﹤0.01% 2462
2025
Q4
$713K Sell
26,765
-762
-3% -$22.5K ﹤0.01% 1844
2025
Q3
$835K Buy
27,527
+1,368
+5% +$41.5K ﹤0.01% 1765
2025
Q2
$820K Sell
26,159
-2,026
-7% -$67K ﹤0.01% 1693
2025
Q1
$1.08M Buy
28,185
+361
+1% +$15.3K ﹤0.01% 1485
2024
Q4
$1.22M Buy
27,824
+530
+2% +$23.3K ﹤0.01% 1457
2024
Q3
$1.18M Buy
27,294
+3,390
+14% +$151K ﹤0.01% 1455
2024
Q2
$1.08M Buy
23,904
+10,141
+74% +$526K ﹤0.01% 1571
2024
Q1
$859K Buy
13,763
+6,611
+92% +$396K ﹤0.01% 1680
2023
Q4
$401K Buy
7,152
+3,261
+84% +$163K ﹤0.01% 2128
2023
Q3
$205K Buy
+3,891
New +$227K ﹤0.01% 2439
2022
Q1
Sell
-2,584
Closed -$204K 2721
2021
Q4
$204K Buy
+2,584
New +$216K ﹤0.01% 2579
2014
Q1
Sell
-1,902
Closed -$208K 799
2013
Q4
$208K Buy
+1,902
New +$190K 0.01% 735

Other funds holding ENOV

Truist Financial's ENOV Position: Q2 2026 in Review

Truist Financial sold out of Enovis (ENOV) in Q2 2026, closing a stake of 11,650 shares — an estimated $265K sold.

Truist Financial first reported a position in ENOV in Q4 2013 and held it in 13 quarters. The position peaked at $1.22M in Q4 2024. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Truist Financial reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
  • Truist Financial sold 11,650 Enovis shares in Q2 2026, an estimated $265K.
  • Truist Financial first reported a position in Enovis in Q4 2013 and held it in 13 quarters.
  • Truist Financial's Enovis position peaked at $1.22M in Q4 2024.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.